INFLUENCE OF FORMULATION FACTORS ON THE SIZE OF NANOSTRUCTURED LIPID CARRIERS AND NANOEMULSIONS PREPARED BY HIGH SHEAR HOMOGENIZATION
Objective: The main purpose of this work was to elucidate the effect of certain formulation factors on the size of nanostructured lipid carriers (NLCs) and nanoemulsions (NEs) by using high shear homogenization method.
Methods: NLCs and NEs were prepared by high shear homogenization method using different liquid lipids types such as (Dermarol DCOÂ® and Dermarol CCTÂ®) at different concentrations. The effect of different concentration ratios of Tween 80 to Span 20 (2.5/1, 5/1, 10/1, 15/1) w/w % and different homogenization speeds (12 000, 18 000 rpm) on the resulted particle size were also studied.
Results: The results revealed that the optimum NLCs and NEs resulted when we use Dermarol CCTÂ® with a concentration of 90 % as liquid lipid and decreasing surfactant ratio to (2.5/1) w/w % with increasing the homogenization speed to 18 000 rpm.Â
Conclusion: NLCs and NEs were successfully prepared, and from this study, it can be concluded that NLCs have the optimum particle size than Nanoemulsions.
2. Sawant KK, Dodiya SS. Recent advances and patents on solid lipid nanoparticles. Recent Pat Drug Delivery Formulation 2008;2:120-35.
3. Prakash RTU, Thiagaraja P. Nanoemulsions for drug delivery through different routes. Res Biotechnol 2011;2:1-13.
4. Sarangi MK, Padhi S. Solid lipid nanoparticlesâ€“a review. J Critical Rev 2016;3:1-8.
5. Mueller RH, Maeder K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug deliveryâ€“a review of the State of the art. Eur J Pharm Biopharm 2000;50:161-77.
6. Yuan H, Wang LL, Du YZ, You J, Hu FQ, Zeng S. Preparation and characteristics of nanostructured lipid carriers for control-releasing progesterone by melt-emulsification. Colloids Surf B 2007;60:174-9.
7. Teeranachaideekul V, MÃ¼ller RH, Junyaprasert VB. Encapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC)-effects of formulation parameters on physicochemical stability. Int J Pharm 2007;340:198-206.
8. MÃ¼ller R, Petersen R, Hommoss A, Pardeike J. Nanostructured lipid carriers (NLC) in cosmetic dermal products. Adv Drug Delivery Rev 2007;59:522-30.
9. Putranti AR, Primaharinastiti R, Hendradi E. Effectivity and physicochemical stability of nanostructured lipid carrier coenzyme Q10 in a different ratio of lipid cetyl palmitate and alpha tocopheryl acetate as a carrier. Asian J Pharm Clin Res 2017;10:146-52.
10. Duarah S, Pujari K, Duran R, Narayanan V. Nanotechnology-based cosmeceuticals: a review. Int J Appl Pharm 2016;8:1-12.
11. Abdelgawad R, Nasr M, Hamza M, Awad G. Topical and systemic dermal carriers for psoriasis. Int J Curr Pharm Res 2016;8:4-9.
12. Tadros T, Izquierdo P, Esquena J, Solans C. Formation and stability of nano-emulsions. Adv Colloid Interface Sci 2004;108:303-18.
13. Mason T, Graves S, Wilking J, Lin M. Extreme emulsification: formation and structure of nanoemulsions. Condens Matter Phys 2006;9:1-8.
14. Graves S, Meleson K, Wilking J, Lin M, Mason T. Structure of concentrated nanoemulsions. J Chem Phys 2005;122:703-6.
15. Jafari SM, He Y, Bhandari B. Optimization of nano-emulsions production by microfluidization. Eur Food Res Technol 2007;225:733-41.
16. Qian C, McClements DJ. Formation of nanoemulsions stabilized by model food-grade emulsifiers using high-pressure homogenization: factors affecting particle size. Food Hydrocolloids 2011;25:1000-8.
17. Uner M. Preparation, characterization and physicochemical properties of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC): their benefits as colloidal drug carrier systems. Die Pharmazie 2006;61:375-86.
18. Suraweera R, Pasansi H, Sakeena M. Assessing the characterizations of ketoprofen loaded and unloaded virgin coconut oil based creamy nanoemulsion. Asian J Pharm Clin Res 2015;8:275-9.
19. Meleson K, Graves S, Mason TG. Formation of concentrated nanoemulsions by extreme shear. Soft Mater 2004;2:109-23.
20. Landfester K, Tiarks F, Hentze HP, Antonietti M. Polyaddition in miniemulsions: a new route to polymer dispersions. Macromol Adv Chem Phys 2000;201:1-5.
21. Wulff-Perez M, Torcello-Gomez A, Galvez-Ruiz M, MartÃn-RodrÃguez A. Stability of emulsions for parenteral feeding: preparation and characterization of O/W nanoemulsions with natural oils and pluronic F68 as a surfactant. Food Hydrocolloids 2009;23:1096-102.
22. Chanana GD, Sheth BB. Particle size reduction of emulsions by formulation design-ii: effect of oil and surfactant concentration. PDA J Pharm Sci Technol 1995;49:71-6.
23. Puglia C, Blasi P, Rizza L, Schoubben A, Bonina F, Rossi C, et al. Lipid nanoparticles for prolonged topical delivery: an in vitro and in vivo investigation. Int J Pharm 2008;357:295-304.
24. Mu L, Feng S. A novel controlled release formulation for the anticancer drug paclitaxel (TaxolÂ®): PLGA nanoparticles containing vitamin E. J Controlled Release 2003;86:33-48.
25. Soleimanian Y, Goli SAH, Varshosaz J, Sahafi SM. Formulation and characterization of novel nanostructured lipid carriers made from beeswax, propolis wax and pomegranate seed oil. Food Chem 2018;244:83-92.
26. Kovacevic A, Savic S, Vuleta G, MÃ¼ller R, Keck C. Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability, and particle matrix structure. Int J Pharm 2011;406:163-72.
27. Lander R, Manger W, Scouloudis M, Ku A, Davis C, Lee A. Gaulin homogenization: a mechanistic study. Biotechnol Prog 2000;16:80-5.